直接的遗传转换绕过了与瘤相关的DNA甲基化变化
Sara Hetzel1,2, Eran Hodis3,4,5, Elena Torlai Triglia3,6
1Max Planck Institute for Molecular Genetics, Berlin, Germany.
Genome biology
|July 17, 2025
概括
工程瘤模型很少复制临床DNA甲基化模式,特别是在Polycomb调节的促进器中. 然而,它们确实显示了与体外增殖相一致的全球甲基化变化,为模型评估提供了分子参考.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 基因组学就是基因组学.
背景情况:
- 瘤是动态的,进化的突变细胞群.
- 了解初始细胞转化条件仍然是一个挑战.
- 转基因细胞和动物系统模型早期瘤发生.
研究的目的:
- 定义人类瘤中常见的DNA甲基化景观特征.
- 基准21与临床数据对比工程模型.
- 评估瘤特异性甲基化模式的模型回顾.
主要方法:
- 利用广泛的患者地图数据进行DNA甲基化分析.
- 将瘤细胞甲基化与健康人体细胞进行比较.
- 评估了21个工程人类和小鼠模型.
主要成果:
- 基因诱导的转化模型很少在临床样本中发现的Polycomb调节的促进体中复制 de novo甲基化.
- 工程模型显示了全球DNA甲基化变化.
- 这些全球变化与广泛的体外增殖相吻合.
结论:
- 研究结果质疑瘤发生过程中遗传和表观遗传因素之间的关系.
- 结果为评估瘤模型提供了分子参考.
- 突出了目前复制临床甲基化场景的工程模型的局限性.
相关概念视频
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Loss of Tumor Suppressor Gene Functions
5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
In-vitro Mutagenesis
14.2K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.2K
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


